Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Biotechnology & Biomaterials received 2154 citations as per Google Scholar report
NEXEL Co. Ltd., South Korea
Keynote: J Biotechnol Biomater
Dong-Hun Woo is a Chief Technology Officer (CTO) at NEXEL Co., Ltd. He received his PhD in Stem Cell Biology from Korea University. During this time, he worked on tissue regeneration through directed differentiation of human pluripotent stem cells into target cell types of the liver, pancreas, and brain. After PhD course, he initially extended his research into cancer stem cells, studying the molecular mechanisms underlying tumorigenicity of cancer stem cells in glioblastoma at the Lerner Research Institute of Cleveland Clinic in Cleveland, OH, USA. Then, he has his expertise in stem cell biology human pluripotent cell fate specification by bringing genome editing strategies to bear on induced pluripotent stem (IPS) cell models of human genetic diseases at the University of Pennsylvania, PA, USA. His current project involves the generation of functional cells from human pluripotent stem cells for drug screening and toxicity tests as Head of research programs at NEXEL Co., Ltd.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals